Page last updated: 2024-08-24

epigallocatechin gallate and Asialia

epigallocatechin gallate has been researched along with Asialia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bisch, F; Derossi, S; Dickinson, D; Hahn, E; Hsu, S; Ma, YH; Ohno, S; Thomas, C; Yamamoto, T; Yates, N; Yu, H	1
Dickinson, D; Hsu, S	1

Reviews

1 review(s) available for epigallocatechin gallate and Asialia

Article	Year
A new approach to managing oral manifestations of Sjogren's syndrome and skin manifestations of lupus. Journal of biochemistry and molecular biology, 2006, May-31, Volume: 39, Issue:3 Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Camellia sinensis; Catechin; Female; Humans; Lupus Erythematosus, Systemic; Male; MAP Kinase Signaling System; Phytotherapy; Salivary Glands; Sjogren's Syndrome; Tea; Xerostomia	2006

Article

Year

A new approach to managing oral manifestations of Sjogren's syndrome and skin manifestations of lupus.

Journal of biochemistry and molecular biology, 2006, May-31, Volume: 39, Issue:3

Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Camellia sinensis; Catechin; Female; Humans; Lupus Erythematosus, Systemic; Male; MAP Kinase Signaling System; Phytotherapy; Salivary Glands; Sjogren's Syndrome; Tea; Xerostomia

2006

Other Studies

1 other study(ies) available for epigallocatechin gallate and Asialia

Article	Year
Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway. Inflammation & allergy drug targets, 2014, Volume: 13, Issue:1 Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Diabetes Mellitus, Type 1; Disease Models, Animal; Down-Regulation; Epithelial Cells; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Proliferating Cell Nuclear Antigen; Retinoblastoma Protein; Salivary Glands; Sjogren's Syndrome; Tumor Suppressor Protein p53; Xerostomia	2014

Article

Year

Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway.

Inflammation & allergy drug targets, 2014, Volume: 13, Issue:1

Topics: Animals; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Diabetes Mellitus, Type 1; Disease Models, Animal; Down-Regulation; Epithelial Cells; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Proliferating Cell Nuclear Antigen; Retinoblastoma Protein; Salivary Glands; Sjogren's Syndrome; Tumor Suppressor Protein p53; Xerostomia

2014